The effectiveness of this massive resale shelf creates a persistent overhang. Traders should expect selling pressure as the selling shareholders unwind positions. Monitor for any takedown notices or Form 4 filings from Oramed and Creative Value Capital. The going-concern risk amplifies the bearish case.
How the stock moved after the report
BEARISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 11 $7.57entry
- T+1 · 3mo ago +2.45%α +2.19% · $7.75
- T+5 · 3mo ago −2.08%α −1.67% · $7.41
- T+20 · 2mo ago −2.18%α −1.12% · $7.40
- T+60 · 13d ago −19.89%α −19.41% · $6.06
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Lifeward Ltd.'s S-3 shelf registration (File No. 333-297919) became effective on August 10, 2026. This allows the company to sell up to 7,256,474 ordinary shares held by selling shareholders Oramed Pharmaceuticals and Creative Value Capital LP, representing approximately 261% of current shares outstanding. The company receives no proceeds from this resale shelf, and the massive potential overhang combined with the auditor's going-concern doubt creates a bearish overhang on the stock.
Key Facts
- Shelf registration 333-297919 declared effective on August 10, 2026.
- Covers 7,256,474 ordinary shares for resale by Oramed Pharmaceuticals and Creative Value Capital LP.
- Shares represent approximately 261% of current shares outstanding.
- Company receives no proceeds from the offering.
- Auditor has expressed substantial doubt about going concern.
Financial Impact
Potential dilution overhang of ~261% of current shares outstanding; no proceeds to company.
Risk Factors
- Massive dilution overhang from selling shareholders.
- Going-concern doubt from auditor.
- No proceeds to company, pure secondary selling.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| EFFECT Filing (Primary) | 9999999995-26-002600 |
| Document: 9999999995-26-002600-index.html | 9999999995-26-002600 |
| Document: 9999999995-26-002600.txt | 9999999995-26-002600 |
Track record
25 reports on LFWD
6 of 7 bullish or bearish reports moved the stock their way by T+5. Best: +20.27% at T+60 after the Aug 14, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 13, 20263d ago Press Release Bearish 6/10 Entry $4.06 Now $3.62 +10.84% settles Nov 20
- Nov 12, 20264d ago 3 Neutral 1/10 Entry $4.06 Now $3.62 −10.84% settles Nov 20
- Nov 3, 202613d ago 3 Neutral 2/10 Entry $6.06 to $5.76 Now $3.62 −40.26% ▼ −4.95% −4.04% vs SPY
- Oct 27, 202620d ago 8-K Neutral 2/10 Entry $6.04 to $5.83 Now $3.62 −40.07% ▼ −3.48% −1.49% vs SPY
- Oct 8, 20265w ago 8-K Bearish 5/10 Entry $6.49 to $6.00 Now $3.62 +44.22% ▲ +7.55% +5.58% vs SPY
- Oct 1, 20266w ago 8-K Neutral 2/10 Entry $5.96 to $6.43 Now $3.62 −39.26% ▲ +7.89% +6.58% vs SPY
- Sep 25, 20267w ago DEF 14A Bearish 7/10 Entry $6.92 to $6.67 Now $3.62 +47.69% ▲ +3.61% +4.82% vs SPY
- Aug 14, 202613w ago 8-K Mixed 6/10 No price data
- Aug 14, 202613w ago Press Release Bearish 6/10 Entry $7.45 to $7.32 Now $3.62 +51.41% ▲ +1.75% +0.38% vs SPY
- Aug 11, 202614w ago EFFECT Bearish 7/10 Viewing Entry $7.57 to $7.41 Now $3.62 +52.15% ▲ +2.08% +1.67% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers